US Stem Cell Inc (USRM)

[Archery Class]

Federal oversight can throw a wrench in things.

The fact that the FDA is even paying attention to our company is impressive in the Pennystock world.

Now another factor is that we were in a reversal pattern before that warning came out. Right here is a good loading zone, so you'll see a lot of buyers getting in under .02.

As long as it consolidates in this channel a little bit and doesn't drop lower, the only remaining factor will be what the FDA or company says next.

There could easily be some positive press coming up here. USRM didn't stay silent about the warning. In fact, they issued a concise reply.